Compared with the placebo group and assuming 100 base pair erosion per year, we can say that the low-dose TA-65 group GAINED SEVEN YEARS of viable telomere length.
Researchers looked at umbilical cord blood samples from 54 newborns and found that lower Socioeconomic status and education were highly correlated with shorter newborn telomeres.